Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
Talazoparib + enzalutamide linked to improved survival for patients with mCRPC unselected for HRR gene alterations
Mobile Prostate Cancer Screening Clinic Can ID the Disease in Disadvantaged Men
127 patients underwent prostate biopsy, with 94 prostate cancers diagnosed; 86.2 percent had clinically significant disease
Testosterone Recovery Linked to Overall Survival in High-Risk Prostate Cancer
Risk for death significantly lower for patients with return of serum testosterone to normal range value
Exercise Regimen Can Improve Fatigue in Patients With Advanced Prostate Cancer
Clinically significant improvement seen in fatigue, and improvement seen in relative peak aerobic capacity with 12-week exercise regimen
Acute Toxicity Following Prostate Radiotherapy Linked to Late Toxicity
Acute genitourinary, GI toxicity linked to late genitourinary or GI toxicity and decrement in urinary or bowel quality of life
Urine-Based Test Provides Accurate Testing Option for Advanced Prostate Cancer
MPS2 provides meaningful improvement in detection of grade group ≥2 cancer relative to PSA-based testing approaches
Opioid Rx in the ED Slightly Raises Risk for Future Opioid Use, Hospitalization
Opioid prescriptions in the emergency department linked to small increases in hospital admission and subsequent opioid prescription use
Effect of Behavioral Intervention on Reducing Care Overuse in Seniors Not Sustained
Persistence of effects of behavioral intervention in older adults varies after discontinuation of intervention
Tonsillectomy Effective for Nocturnal Enuresis in Children With Sleep Apnea
Pooled overall remission and complete remission of nocturnal enuresis only 37.3 percent based on randomized controlled trials
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
Improvement in urinary symptoms with better preservation of ejaculatory function seen with double-n technology